1-1 of 1
Klaus Podar, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of the mTOR Inhibitor Rapamycin and Revlimid™ (CC-5013) Has Synergistic Activity in Multiple Myeloma (MM).

Noopur Raje, MD, Shaji Kumar, MD, Teru Hideshima, MD, PhD, Kenji Ishitsuka, MD, Dharminder Chauhan, PhD, Constantine Mitsiades, MD, PhD, Klaus Podar, PhD, Steven Le Gouill, MD, Paul Richardson, MD, Nikhil C. Munshi, MD, David I. Stirling, PhD, Joseph H. Antin, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2004) 104 (11): 1492.
https://doi.org/10.1182/blood.V104.11.1492.1492
Published: 2004